Novo Nordisk
- Hot News
Inside Novo’s $2.1 Billion Gamble on Omeros — What This Means for the Future of Medicine
On October 15, 2025, Novo Nordisk — the Danish pharmaceutical giant known globally for insulin and for turning GLP-1 drugs…
Read More »
On October 15, 2025, Novo Nordisk — the Danish pharmaceutical giant known globally for insulin and for turning GLP-1 drugs…
Read More »